TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection

N Iwata-Yoshikawa, T Okamura, Y Shimizu… - Journal of …, 2019 - Am Soc Microbiol
Transmembrane serine protease TMPRSS2 activates the spike protein of highly pathogenic
human coronaviruses such as severe acute respiratory syndrome-related coronavirus (…

[HTML][HTML] Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways

N Iwata-Yoshikawa, M Kakizaki, N Shiwa-Sudo… - Nature …, 2022 - nature.com
In cultured cells, SARS-CoV-2 infects cells via multiple pathways using different host
proteases. Recent studies have shown that the furin and TMPRSS2 (furin/TMPRSS2)-dependent …

[HTML][HTML] Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus

CT Tseng, E Sbrana, N Iwata-Yoshikawa, PC Newman… - PloS one, 2012 - journals.plos.org
Background Severe acute respiratory syndrome (SARS) emerged in China in 2002 and
spread to other countries before brought under control. Because of a concern for reemergence …

Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related …

N Iwata-Yoshikawa, A Uda, T Suzuki… - Journal of …, 2014 - Am Soc Microbiol
Severe acute respiratory syndrome-related coronavirus (SARS-CoV) is an emerging pathogen
that causes severe respiratory illness. Whole UV-inactivated SARS-CoV (UV-V), bearing …

A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection

N Iwata-Yoshikawa, N Shiwa, T Sekizuka, K Sano… - Science …, 2022 - science.org
One safety concern during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine development has been the vaccine-associated enhanced disease, which is …

Gold nanoparticle‐adjuvanted S protein induces a strong antigen‐specific IgG response against severe acute respiratory syndrome‐related coronavirus infection, but …

H Sekimukai, N IwataYoshikawa… - Microbiology and …, 2020 - Wiley Online Library
The spike (S) protein of coronavirus, which binds to cellular receptors and mediates
membrane fusion for cell entry, is a candidate vaccine target for blocking coronavirus infection. …

[PDF][PDF] Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants

…, Y Inoue, Y Kaku, M Tobiume, N Iwata-Yoshikawa… - Med, 2022 - cell.com
Background The immune profile against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has dramatically diversified due to a complex combination of exposure to …

Lethal canine distemper virus outbreak in cynomolgus monkeys in Japan in 2008

…, Y Ami, F Seki, Y Suzaki, N Iwata-Yoshikawa… - Journal of …, 2013 - Am Soc Microbiol
Canine distemper virus (CDV) has recently expanded its host range to nonhuman primates.
A large CDV outbreak occurred in rhesus monkeys at a breeding farm in Guangxi Province, …

Acute respiratory infection in human dipeptidyl peptidase 4-transgenic mice infected with Middle East respiratory syndrome coronavirus

N Iwata-Yoshikawa, T Okamura, Y Shimizu… - Journal of …, 2019 - Am Soc Microbiol
Middle East respiratory syndrome coronavirus (MERS-CoV) infection can manifest as a mild
illness, acute respiratory distress, organ failure, or death. Several animal models have been …

Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus

…, S Taniguchi, T Yoshikawa, N Iwata-Yoshikawa… - MSphere, 2016 - Am Soc Microbiol
Severe fever with thrombocytopenia syndrome virus (SFTSV) is the causative agent of SFTS,
an emerging hemorrhagic fever. This disease has a high case fatality rate and is endemic …